As part of our Special SBS Alumni Seminar Series, we have invited Dr Thomas Jun Feng Lim, a Scientist from Medpace Research Laboratories to share more on his career.
Dr. Lim obtained his BSc (2014) and PhD (2019) in Biological Sciences from NTU. During his graduate studies in Su I-Hsin’s lab, he studies the functional role of the integrin activator Talin1. After a short postdoc, he became a Scientist at Medpace, a clinical contact research organization.
Dr. Lim will discuss the career prospects of a biological science graduate in the clinical trial industry. Clinical trials evaluate the safety and functionality of new therapeutics in the human body, essentially bridging translational/clinical research and drug development into real world benefits. Pharmaceuticals and biotech companies typically engage Contract Research Organizations (CRO) to manage clinical trials around the world. CRO can be broken down into several functional areas such as the central laboratory, regulations, and project management. Unlike most industries, clinical trial management is highly resilient to economic downturns, and even experienced growth during the on-going COVID-19 pandemic.